Skip to main content
Loading

Ocuphire

Tuesday, February 27, 2024
Plymouth
Ophthalmology
Ocuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders.
Speakers
George Magrath, CEO - Ocuphire

State

MI

Country

United States

Website

https://www.ocuphire.com/

CEO/Top Company Official

George Magrath

Lead Product in Development

APX3330

Development Phase of Primary Product

Phase III

Number Of Unlicensed Products

1
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP